Mont. Admin. r. 24.174.501 - EXAMINATION FOR LICENSURE AS A REGISTERED PHARMACIST

(1) The board has selected the National Association of Boards of Pharmacy (NABP) licensure examination (NAPLEX) to be administered to candidates for licensure in Montana. The examination shall be prepared to measure the competence of the applicant to engage in the practice of pharmacy. A score of 75 shall be a passing score for this examination. A candidate who does not attain this score may retake the examination pursuant to NABP requirements.

(2) In addition, the NABP shall administer a multistate pharmacy jurisprudence examination (MPJE). This examination shall be prepared to measure the competence of the applicant regarding the statutes and rules governing the practice of pharmacy. A score of not less than 75 shall be a passing score for this examination. A candidate who does not attain this score may retake the examination after a 30-day waiting period from the date of the exam.

(3) Pharmacy graduates from outside the 50 states, the District of Columbia, or Puerto Rico, who seek certification of educational equivalency in order to sit for the North American pharmacist licensure examination must also complete the following:

(a) an interview before the Board of Pharmacy or its designee;

(b) 1500 hours of internship in the United States;

(c) receive a Foreign Pharmacy Graduate Examination Committee (FPGEC) Certification from NABP, which includes the following:

(i) Foreign Pharmacy Graduate Equivalency Examination (FPGEE);

(ii) Test of Spoken English (TSE); and

(iii) Test of English as a Foreign Language (TOEFL).

(4) NABP minimum passing scores must be achieved on all tests and examinations.

Notes

Mont. Admin. r. 24.174.501

NEW, Eff. 11/25/77; TRANS, from Dept. of Prof. & Occup. Lic., Ch. 274, L. 1981, Eff. 7/1/81; AMD, 1983 MAR p. 344, Eff. 4/29/83; AMD, 1986 MAR p. 945, Eff. 5/30/86; AMD, 2002 MAR p. 178, Eff. 2/1/02; TRANS, from Commerce, 2002 MAR p. 904; AMD, 2002 MAR p. 3605, Eff. 12/27/02; AMD, 2007 MAR p. 1936, Eff. 11/22/07; AMD, 2011 MAR p. 1148, Eff. 6/24/11; AMD, 2016 MAR p. 1696, Eff. 9/24/2016; AMD, 2018 MAR p. 1825, Eff. 9/8/2018

AUTH: 37-1-131, 37-7-201, MCA; IMP: 37-1-131, 37-7-201, 37-7-302, MCA